Clinical trial
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
NCT01398306 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
- Lead sponsor
- University Medical Center Groningen
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- April 30, 2012
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoid tumor, carcinoma, carcinoma, renal cell, neuroendocrine tumors, pancreatic islet cell tumors